This opportunity is no longer accepting applications.
grant RFA-HL-23-013

Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)

This grant opportunity offers early stage funding to support the development and testing of medical device prototypes, identification of disease targets, and creation of diagnostic assays for heart, lung, blood, and sleep (HLBS) disorders. It is part of a series of grants aimed at advancing projects to a stage where they can transition to later preclinical development programs or attract addit…

This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to develop and test device prototype designs, identify diagnostic disease targets and develop associated assays, and develop research tools for use in the treatment o…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute

Dates

Opportunity Released: January 24, 2022
Open for Submission: January 24, 2022
Submission Deadline: December 20, 2024
Application Window Closes: December 20, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.